Zivo Bioscience, Inc. financial data

Symbol
ZIVO, ZIVOW on OTC
Location
21 E. Long Lake Road, Suite 100, Bloomfield Hills, MI
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 34.4 % +14.3%
Debt-to-equity -162 % -6.79%
Return On Assets -932 % +28.8%
Operating Margin -5.54K % +74.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.82M shares +13.4%
Common Stock, Shares, Outstanding 3.82M shares +15%
Entity Public Float 15.6M USD -9.83%
Common Stock, Value, Issued 3.82K USD +15%
Weighted Average Number of Shares Outstanding, Diluted 3.81M shares +28.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 175K USD +195%
Revenue from Contract with Customer, Excluding Assessed Tax 175K USD +195%
Research and Development Expense 3.82M USD +23.3%
General and Administrative Expense 5.93M USD -40%
Operating Income (Loss) -9.7M USD +25.3%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -9.72M USD +26.6%
Earnings Per Share, Diluted -0.43 USD/shares +84.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 410K USD -17.2%
Property, Plant and Equipment, Net 0 USD
Operating Lease, Right-of-Use Asset 286K USD +490%
Assets 703K USD +22.2%
Accounts Payable, Current 861K USD -21.3%
Accrued Liabilities, Current 1.43M USD +43%
Liabilities, Current 2.96M USD +3.08%
Operating Lease, Liability, Noncurrent 238K USD
Liabilities 3.24M USD +13%
Retained Earnings (Accumulated Deficit) -143M USD -7.3%
Stockholders' Equity Attributable to Parent -2.54M USD -10.7%
Liabilities and Equity 703K USD +22.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.43M USD +15.8%
Net Cash Provided by (Used in) Financing Activities 405K USD -74.1%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 25M shares 0%
Common Stock, Shares, Issued 3.82M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.82K USD +298%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.4K USD +16.7%
Deferred Tax Assets, Valuation Allowance 13.7M USD +10.9%
Operating Lease, Liability 301K USD
Lessee, Operating Lease, Liability, to be Paid 378K USD
Operating Lease, Liability, Current 63.2K USD +24.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 46.1K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 3K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 77.2K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 94.7K USD
Preferred Stock, Shares Issued 3.49M shares +100%
Lessee, Operating Lease, Liability, to be Paid, Year Four 97.7K USD
Additional Paid in Capital 140M USD +7.25%
Deferred Tax Assets, Net of Valuation Allowance 13.7M USD +10.9%
Interest Expense 7.36K USD +8.78%